The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, Government of India, has taken another significant step towards digital transformation. As per the circular dated 12th February 2025, CDSCO has introduced an online provision for…


Jan 6, 2025 In a significant development for Micro, Small, and Medium Enterprises (MSME) in the pharmaceutical sector, the Ministry of Health and Family Welfare (MoHFW) has proposed an extension for compliance with the updated Good Manufacturing Practice (GMP) standards…

December 30, 2024 In a bid to streamline the process of clinical trial approvals in India, the Central Drugs Standard Control Organization (CDSCO) has enhanced the functionalities of the Sugam Portal, allowing sponsors and researchers to efficiently submit clinical trial…

December 16, 2024 In a significant move to support patients battling rare diseases, the Central Drugs Standard Control Organization (CDSCO), India’s apex drug regulatory body, has directed drug regulators across the country to fast-track the approval process for medications and…

Loan Licensing in Pharmaceutical Manufacturing: Key Principles, Guidelines, and Regulatory Framework
Loan licensing in pharmaceutical manufacturing plays a crucial role by allowing companies to outsource manufacturing or testing operations to third-party facilities. This setup, governed by the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, helps pharmaceutical…
Recent Post
- Complete List of Banned Drugs in India
- Government Mandates Online CRO Registration via SUGAM Portal!
- NPPA Directs Drug Price Cuts Following Customs Duty Exemptions
- CDSCO Issues Urgent Directive for Category D FDC Manufacturers: Submit Applications by May 24, 2025
- Navigating Regulatory Changes: Gastro-Resistant & Delayed-Release Drugs as ‘New’ Under NDCT Rules 2019